In vitro dissolution testing models of ocular implants for posterior segment drug delivery

Adrianto, Muhammad Faris and Annuryanti, Febri and Wilson, Clive G. and Sheshala, Ravi and Thakur, Raghu Raj Singh (2021) In vitro dissolution testing models of ocular implants for posterior segment drug delivery. Drug Delivery and Translational Research. ISSN 2190-393X (https://doi.org/10.1007/s13346-021-01043-z)

[thumbnail of Faris-Adrianto-etal-DDTR-2021-In-vitro-dissolution-testing-models-of-ocular-implants-for-posterior-segment-drug-delivery]
Preview
 Text. Filename: Faris_Adrianto_etal_DDTR_2021_In_vitro_dissolution_testing_models_of_ocular_implants_for_posterior_segment_drug_delivery.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo
Download (2MB)| Preview

Abstract

The delivery of drugs to the posterior segment of the eye remains a tremendously difficult task. Prolonged treatment in conventional intravitreal therapy requires injections that are administered frequently due to the rapid clearance of the drug molecules. As an alternative, intraocular implants can offer drug release for long-term therapy. However, one of the several challenges in developing intraocular implants is selecting an appropriate in vitro dissolution testing model. In order to determine the efficacy of ocular implants in drug release, multiple in vitro test models were emerging. While these in vitro models may be used to analyse drug release profiles, the findings may not predict in vivo retinal drug exposure as this is influenced by metabolic and physiological factors. This review considers various types of in vitro test methods used to test drug release of ocular implants. Importantly, it discusses the challenges and factors that must be considered in the development and testing of the implants in an in vitro setup.

CORE (COnnecting REpositories)